Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Chaisson

Showing results (171-180 of 241) with videos related to

Pageof 25
Sort By:
AIDS (London, England)|June 26, 2007
The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, BrazilJonathan E Golub, Valeria Saraceni, Solange C Cavalcante, et al.
The Indian Journal of Tuberculosis|March 21, 2020
High prevalence of rifampin-resistant tuberculosis in mountainous districts of IndiaKunchok Dorjee, Tsetan D Sadutshang, Ravinder S Rana, et al.
Plos Medicine|December 21, 2007
Daily dosing of rifapentine cures tuberculosis in three months or less in the murine modelIan M Rosenthal, Ming Zhang, Kathy N Williams, et al.
IRB|June 21, 2014
Applying ethical principles to international community-based research: a case study from the Consortium to Respond Effectively to the AIDS-TB Epidemic (CREATE) Nancy E Kass, Andrea N DeLuca, Leonie Coetzee, et al.
AIDS (London, England)|September 23, 2003
Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?Gavin J Churchyard, Katherine Fielding, Salome Charalambous, et al.
Pharmacogenetics and Genomics|August 21, 2020
Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapineDavid W Haas, Anthony T Podany, Yajing Bao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2023
Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First TrimesterAmita Gupta, Michael D Hughes, Jorge Leon Cruz, et al.
The Journal of Infectious Diseases|June 7, 2003
Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patientsLynn Morris, Desmond J Martin, Helba Bredell, et al.
The Journal of Infectious Diseases|August 2, 2014
Pharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfectionKelly E Dooley, Paolo Denti, Neil Martinson, et al.
Drugs|December 29, 2024
Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art ReviewViolet Chihota, Makaita Gombe, Amita Gupta, et al.
Pageof 25

Showing results (171-180 of 241) with videos related to

Sort By:
Pageof 25
AIDS (London, England)|June 26, 2007
The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, BrazilJonathan E Golub, Valeria Saraceni, Solange C Cavalcante, et al.
The Indian Journal of Tuberculosis|March 21, 2020
High prevalence of rifampin-resistant tuberculosis in mountainous districts of IndiaKunchok Dorjee, Tsetan D Sadutshang, Ravinder S Rana, et al.
Plos Medicine|December 21, 2007
Daily dosing of rifapentine cures tuberculosis in three months or less in the murine modelIan M Rosenthal, Ming Zhang, Kathy N Williams, et al.
IRB|June 21, 2014
Applying ethical principles to international community-based research: a case study from the Consortium to Respond Effectively to the AIDS-TB Epidemic (CREATE) Nancy E Kass, Andrea N DeLuca, Leonie Coetzee, et al.
AIDS (London, England)|September 23, 2003
Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?Gavin J Churchyard, Katherine Fielding, Salome Charalambous, et al.
Pharmacogenetics and Genomics|August 21, 2020
Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapineDavid W Haas, Anthony T Podany, Yajing Bao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2023
Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First TrimesterAmita Gupta, Michael D Hughes, Jorge Leon Cruz, et al.
The Journal of Infectious Diseases|June 7, 2003
Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patientsLynn Morris, Desmond J Martin, Helba Bredell, et al.
The Journal of Infectious Diseases|August 2, 2014
Pharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfectionKelly E Dooley, Paolo Denti, Neil Martinson, et al.
Drugs|December 29, 2024
Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art ReviewViolet Chihota, Makaita Gombe, Amita Gupta, et al.
Pageof 25